Medscape5d
Fidaxomicin: A New Macrocyclic, RNA Polymerase-inhibiting Antibiotic for the Treatment of Clostridium difficile Infections
Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...
Medscape3d
Better Outcomes With Antithrombotics: Here’s How PPIs Help
Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...
European Medical Journal17h
Ulcerative Colitis and Clostridioides difficile: New Insights into Infection Risk
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
CNN3d
Canned tuna sold at Trader Joe’s, Costco, Walmart and more recalled due to botulism risk
Without proper sealing, the company said, there’s a risk of food leaking or contamination with Clostridium botulinum, or botulism. No illnesses have been reported in connection with the recalled ...
BMJ Open5d
Practices and knowledge of community pharmacists towards the use of proton pump inhibitors: a cross-sectional study in Jordan
Objectives The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on ...
gut.bmj4d
Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease
Patients with ulcerative colitis (UC) are at increased risk of colorectal carcinoma. 1, 2 Many clinicians practice colonoscopic surveillance in these patients in the hope of detecting dysplasia or an ...